Gilead Sciences, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-7.07 | $-6.75 | +4.5% | Beat |
| Q12026 FY2026 | $1.89 | $2.03 | +7.4% | Beat |
| Q42025 FY2025 | $1.87 | — | — | Miss |
Back to GILD overview · GILD holders · GILD KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.